Clinical Trials Logo

Filter by:
NCT ID: NCT02183194 Withdrawn - Clinical trials for Dysfunctional AV Graft

Paclitaxel Coated PTA Balloons for Treatment of Dysfunctional AV Fistulae and Grafts

ACCESS
Start date: July 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the Lutonix® 035 Drug Coated Balloon PTA Catheter (CE mark) for use as intended in the treatment of subjects with clinically significant hemodialysis vascular access stenosis or occlusion.

NCT ID: NCT02144129 Withdrawn - Ulcerative Colitis Clinical Trials

Effects of WB-EMS in Ulcerative Colitis Patients

Start date: March 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effect of 12 weeks of WB-EMS either applicated passive in a supine resting position or active during slight movements compared with a non-training control group on body composition, muscle strength and QoL in patients with ulcerative colitis. Our main hypothesis is that active WB-EMS application is significantly more favorable to address our primary endpoints compared with passive application. Our secondary hypothesis is that passive WB-EMS application is significantly more favorable to address our primary endpoints compared with non-training control.

NCT ID: NCT02107222 Withdrawn - Clinical trials for Chronic Obstructive Pulmonary Disease

The PALP™-COPD Trial (Low-Flow CO2-Removal (ECCO2-R) in Exacerbated COPD)

PALP-COPD
Start date: n/a
Phase: N/A
Study type: Interventional

A Multicenter, Randomized, Controlled Trial to Determine Safety and Efficacy of Pump Assisted Lung Protection (PALP™) for Low Flow Carbon Dioxide (CO2) Removal in Conjunction with Liberation from Mechanical Ventilation Compared to Mechanical Ventilation Alone in Patients with COPD Exacerbation and Respiratory Failure

NCT ID: NCT02095236 Withdrawn - Tumor Clinical Trials

Evaluation of Intrafractional Motion of Liver Tumors Using Markers

ESMERALDA
Start date: n/a
Phase: N/A
Study type: Interventional

Radioopaque fiducial markers or electro-magnetic transponders will be implanted into or in close proximity of the tumor. During a radiotherapy treatment session image and/or signal acquisition will be performed by ultrasound, computed tomography, magnetic resonance imaging or by specialized signal detectors The data will help to characterize tumor and organ motion during one treatment session which may in fact have impact on dose distribution

NCT ID: NCT02087280 Withdrawn - Anorexia Nervosa Clinical Trials

Metabolic Phenotyping in Anorexia Nervosa

Start date: October 2014
Phase: N/A
Study type: Observational

After discharge from inpatient treatment, 30-50% of patients with Anorexia Nervosa require re-hospitalization within 4-12 months. So far, high relapse rates are mostly considered as lack of the patient's compliance and motivation to recover. However in studies, psychological relapse predictors explain only a minor part of the variance in relapse risk. Metabolic phenotyping has clinical value to predict weight course in obese patients and we assume that it could also be clinically relevant in patients with AN. We hypothesize that in patients with a dissipative but not with the thrifty phenotype, positive energy balance during refeeding causes an over proportional rise in energy expenditure, counteracts continuous weight gain during inpatient treatment, and increases relapse risk within one year after discharge. Thus we believe that metabolic phenotype as a biological parameter has prognostic value for the disease course in AN.

NCT ID: NCT02085668 Withdrawn - Clinical trials for Chronic Heart Failure

Renal Denervation in Patients With Chronic Heart Failure

Start date: May 2014
Phase: N/A
Study type: Interventional

The purpose of the trial is to investigate the safety and effectiveness of renal denervation for the treatment of chronic heart failure (CHF).

NCT ID: NCT02072538 Withdrawn - Clinical trials for Major Adverse Cardiovascular Events

Pre-discharge vs. Early Post-discharge Stress Testing and GRACE Score for Safe Discharge of ACS-patients With a Negative Hs-troponin T Result

Start date: April 2014
Phase: N/A
Study type: Observational [Patient Registry]

New high-sensitivity cardiac troponin (hs-cTn) assays allow earlier detection of acute myocardial infarction (AMI). Furthermore, elevated values were associated with an increased risk of recurrent AMI or death. Therefore, guidelines recommend an early invasive strategy in patients with elevated admission values and kinetic changes. Other criteria for an early invasive strategy include a GRACE risk score >140 points or other cardiovascular risk factors. Hs-cTn assays allow discrimination of patients at very low and high risk. Studies confirmed safety of early discharge protocols in patients with unstable angina (UAP). The aim of this study is to 1) confirm the safety of early discharge without invasive strategy in patients with UAP and to 2) review the optimal timing of stress-testing. Therefore, patients are being randomized into 2 groups with pre-discharge and early post-discharge stress-testing. Endpoints are major adverse cardiovascular events within 30 and 90 days.

NCT ID: NCT02009410 Withdrawn - Clinical trials for Exocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2

A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects With Diabetes Mellitus Type 2

Start date: November 2013
Phase: Phase 4
Study type: Interventional

maldigestion of dietary macronutrients (pancreas not producing enough enzymes for digestion of fat, sugars and proteins) in diabetes type II

NCT ID: NCT01997827 Withdrawn - Clinical trials for Unsatisfactory or Defective Restoration of Tooth

Minimal Invasive Rehabilitation of Tooth Loss in the Anterior Segment

MIZE-F
Start date: October 2013
Phase: N/A
Study type: Interventional

Tooth loss can be addressed by different rehabilitative strategies. Implant-supported crowns and conventional bridges (fixed dental prostheses [FDPs]) are well established treatment alternatives. Implant therapy is sometimes impossible, however, because of patient-related risk factors or economic issues. In such cases therapy with an FDP requires extensive removal of tooth structure to provide enough space for the restoration and to ensure mechanical retention if the abutment teeth are sound. Alternatives for rehabilitation requiring minor or no preparation of the anchoring teeth are desirable. Resin-bonded bridges meet this demand for minimal invasiveness and have been used clinically successfully. Sometimes, however, patients choose a conventional FDP over a resin-bonded one (RBFDP) for esthetic reasons since the adhesive wings, which are traditionally made of a cobalt-chromium alloy, might be exposed while speaking or smiling or account for a colour change of the abutment teeth. Such patients profit from an all-ceramic RBFDP. Today, the clinical performance of metal-based and all-ceramic RBFDPs has not yet been evaluated under randomized controlled conditions. The aim of this pilot study is to calculate the sample size that allows us to accept the hypothesis that metal- and all-ceramic RBFDPs are similar regarding their clinical performance with adequate statistical power.

NCT ID: NCT01992276 Withdrawn - Influenza Clinical Trials

Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection

Start date: December 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the rate of decline in quantitative viral load measured in hospitalized patients with Influenza A infection